Volibo M 0.2/500mg
| SKU | 2603 |
|---|---|
| Generic For | Voglibose |
| Manufacturer | Sun Pharmaceuticals Ltd |
| Active Ingredient | Voglibose/Metformin Hcl |
| Pack Size | Qty | Price Per Pill or Unit | Price | Cart | |
|---|---|---|---|---|---|
| 30 Tablet/s | US$ 0.64 | US$ 19.20 | |||
|
|||||
| 60 Tablet/s | US$ 0.58 | US$ 34.5610%US$ 38.40 | |||
|
|||||
| 90 Tablet/s | US$ 0.54 | US$ 48.9615%US$ 57.60 | |||
|
|||||
Volibo M 0.2/500mg – Affordable Voglibose Alternative
Volibo M 0.2/500 mg is a combination of Voglibose and metformin. It is used when other medicines and lifestyle changes are insufficient to manage your diabetes. You may need Volibo M, healthy eating, and physical activity to manage your Type 2 diabetes. You can take this antidiabetic agent orally by mouth. Oral medication act in a way that lowers the sugar level in the bloodstream.
Each Volibo M 0.2/500 tablet combines Metformin and Voglibose as the active ingredients. Metformin helps decreases blood glucose by decreasing hepatic glucose production. At the same time, Voglibose improves blood sugar levels in insulin-dependent diabetic patients with intensive insulin therapy. The excellent safety profile and tolerability, coupled with moderate efficacy, make them suitable for use as monotherapy.
Do not take Volibo M 0.2/500 if you are allergic to Metformin, Voglibose, or other medicine ingredients. Also, avoid taking the fixed-dose combination diabetes medicine if you have Type 1 diabetes, severe liver disease, or diabetic ketoacidosis (when the blood acid level in your body is raised). Talk to your doctor if you have kidney problems, severe illness, liver problems, or you are about to have major surgery.
The oral antidiabetic medicine may affect your ability to drive or operate machines if your blood sugar is low or high. Keep in your mind that you could endanger yourself or others.
Some diabetes medicines, including Volibo M 0.2/500, can cause Hypoglycaemia (low blood glucose) if you do not balance your medicines with foods and activity or take any other antidiabetic drug. Ask your doctor how you can treat episodes of Hypoglycaemia. Other side effects of the medicine are upset stomach and weight gain.
How to use Volibo M 0.2/500
Volibo M 0.2/500 is available in the form of a tablet that should be taken every day at about the same time. Swallow the pill whole with water without breaking, crushing, or chewing it. Tell your doctor if you are pregnant, planning to conceive, or breastfeeding. Your health care specialist may perform routine blood tests to check for low blood sugar levels and to ensure proper metabolic function. Let your doctor know if you find any changes in your weight, especially if you gain weight. Continue to take medicine until the prescribed amount is over, or even if symptoms disappear after a few doses. Stopping the medicine before the prescribed time may result in the return of the infection.
Tell your doctor if you cannot find improvement even after completing the course or if your condition worsens. If a user has overdosed accidentally and has serious symptoms such as trouble breathing, immediately rush to an emergency care room.
What is Voglibose/Metformin HCl and what condition does it treat?
Voglibose/Metformin HCl is a combination antidiabetic medication used to treat type 2 diabetes mellitus. Volibo M 0.2/500mg combines two active ingredients: voglibose, an alpha-glucosidase inhibitor, and metformin hydrochloride, a biguanide. This dual-action diabetes medicine helps control high blood sugar levels in adults when diet and exercise alone are insufficient. The combination therapy addresses multiple mechanisms of glucose regulation, making it particularly effective for patients who need more than one diabetes medication to achieve optimal glycemic control and reduce long-term complications.
How does Voglibose/Metformin HCl work in the body?
Volibo M 0.2/500mg works through two complementary mechanisms to manage blood sugar. Voglibose slows down carbohydrate digestion in the intestines by blocking alpha-glucosidase enzymes, which delays glucose absorption and prevents post-meal blood sugar spikes. Metformin HCl reduces glucose production in the liver, improves insulin sensitivity in muscle tissue, and decreases sugar absorption in the gut. This dual-action glucose control medication targets both dietary sugar intake and internal glucose metabolism, providing comprehensive blood sugar management throughout the day for people with type 2 diabetes.
How long does Volibo M 0.2/500mg take to work?
Volibo M 0.2/500mg begins working within hours of taking your first dose, with voglibose affecting post-meal glucose levels almost immediately and metformin starting to reduce blood sugar within a few hours. However, the full therapeutic benefits of this combination diabetes medication typically become apparent after one to two weeks of consistent use. Maximum blood sugar control and HbA1c improvements are usually observed after two to three months of regular treatment. Your healthcare provider will monitor your glucose levels periodically to assess how effectively this antidiabetic therapy is managing your condition.
When and how should I take Volibo M 0.2/500mg?
Take Volibo M 0.2/500mg exactly as prescribed by your doctor, typically with meals to minimize gastrointestinal side effects and maximize effectiveness. This combination diabetes tablet is usually taken two or three times daily with the first bite of your main meals. Swallow the tablet whole with water—do not crush or chew it. Taking this blood sugar medication with food helps voglibose work on the carbohydrates you're eating while reducing metformin's potential stomach upset. Maintain consistent timing with your meals for optimal glucose control throughout the day.
Is Volibo M 0.2/500mg safe for long-term use?
Volibo M 0.2/500mg is generally considered safe for long-term diabetes management when used under medical supervision. Many patients with type 2 diabetes take this combination antidiabetic medication for years as part of their ongoing treatment plan. Regular monitoring of kidney function, liver enzymes, and vitamin B12 levels is recommended during extended therapy with metformin-containing medicines. Long-term studies show that voglibose/metformin combinations maintain their effectiveness over time without significant tolerance development. Your healthcare provider will conduct periodic health assessments to ensure this glucose-lowering medication remains appropriate and beneficial for your individual needs.
Can I take Volibo M 0.2/500mg with other medicines?
Volibo M 0.2/500mg can interact with various medications, so inform your doctor about all medicines you're taking. This diabetes combination therapy may interact with other blood sugar medications, potentially increasing hypoglycemia risk. Certain drugs like corticosteroids, diuretics, and thyroid medications can affect glucose levels and may require dose adjustments. Contrast dyes used in imaging procedures may necessitate temporary discontinuation of metformin. Inform healthcare providers that you're taking this antidiabetic medicine before any surgical procedures or diagnostic tests. Maintaining an updated medication list helps prevent dangerous drug interactions.
How does Volibo M 0.2/500mg compare to similar medicines in its class?
Volibo M 0.2/500mg offers advantages over single-ingredient diabetes medications by combining two mechanisms in one tablet. Compared to metformin alone, adding voglibose provides better post-meal glucose control. Versus other alpha-glucosidase inhibitors like acarbose, voglibose often causes fewer gastrointestinal side effects. This combination antidiabetic therapy is particularly effective for patients with elevated postprandial blood sugar. Alternative combinations exist with different ingredient ratios or substitute agents like sulfonylureas or DPP-4 inhibitors, but voglibose/metformin specifically targets both carbohydrate absorption and insulin resistance without causing weight gain or significant hypoglycemia risk when used appropriately.
Is the generic Voglibose/Metformin HCl as effective as branded versions?
Generic voglibose/metformin HCl is equally effective as branded versions like Volibo M 0.2/500mg. Regulatory agencies in the USA, UK, Australia, and Canada require generic diabetes medications to demonstrate bioequivalence to brand-name products, meaning they contain identical active ingredients in the same strengths and work identically in your body. Generic antidiabetic medicines undergo rigorous testing to ensure therapeutic equivalence. The primary difference is price—generics typically cost significantly less while delivering the same blood sugar control. Whether you choose branded or generic versions of this combination diabetes therapy, you receive clinically equivalent glucose-lowering benefits.
Why do patients choose PremiumRxDrugs for Volibo M 0.2/500mg?
Patients select PremiumRxDrugs for Volibo M 0.2/500mg because of guaranteed authenticity, competitive pricing, and reliable international delivery. As a licensed pharmacy, we have been serving diabetes patients worldwide for more than ten years, building reputation through consistent quality. PremiumRxDrugs offers easy prescription management and reordering systems that simplify ongoing diabetes treatment. Free shipping options make this combination antidiabetic medication more accessible financially. Discreet packaging ensures privacy, while manufacturer-sourced medicines guarantee you're receiving genuine voglibose/metformin HCl products. The pharmacy's licensing across multiple countries and transparent operations provide peace of mind when purchasing essential glucose-control medications online.
What are the common side effects of Voglibose/Metformin HCl?
Common side effects of voglibose/metformin HCl include gastrointestinal symptoms such as nausea, diarrhea, abdominal discomfort, bloating, and gas. The voglibose component may cause flatulence due to undigested carbohydrates reaching the colon, while metformin often causes temporary digestive upset. These side effects of this combination diabetes medicine typically diminish as your body adjusts to treatment. Some patients experience a metallic taste or decreased appetite. Taking this antidiabetic medication with meals significantly reduces stomach-related reactions. Serious but rare side effects include lactic acidosis and vitamin B12 deficiency with prolonged use. Most people tolerate this glucose-lowering therapy well once adjusted.
Who should avoid taking Voglibose/Metformin HCl?
People with severe kidney disease, liver impairment, or metabolic acidosis should avoid voglibose/metformin HCl. This combination diabetes medication is contraindicated for those with diabetic ketoacidosis, heart failure requiring medication, or conditions causing tissue hypoxia. Patients with chronic intestinal disorders like inflammatory bowel disease or intestinal obstruction should not use this antidiabetic therapy. Those allergic to voglibose, metformin, or related ingredients must avoid it. Pregnant or breastfeeding women typically require alternative glucose control options. Individuals scheduled for surgery or imaging with contrast dye may need temporary discontinuation. Always disclose your complete medical history before starting any diabetes treatment.
Login
Sign Up
Login
Sign Up